Clinical trial
Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Acute Myocardial Infarction
NCT04340609 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Acute Myocardial Infarction
- Lead sponsor
- PT. Prodia Stem Cell Indonesia
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 11, 2019
- Completion date
- April 8, 2022
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction